Mori Giorgia
Mori Giorgia
PostDoc, University of Queensland, Diamantina institute
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
J Neres, RC Hartkoorn, LR Chiarelli, R Gadupudi, MR Pasca, G Mori, ...
ACS chemical biology 10 (3), 705-714, 2015
762015
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis
ALJL Ribeiro, G Degiacomi, F Ewann, S Buroni, ML Incandela, ...
PloS one 6 (11), e26675, 2011
512011
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
G Mori, LR Chiarelli, M Esposito, V Makarov, M Bellinzoni, RC Hartkoorn, ...
Chemistry & biology 22 (7), 917-927, 2015
412015
Design, syntheses, and anti-TB activity of 1, 3-benzothiazinone azide and click chemistry products inspired by BTZ043
R Tiwari, PA Miller, LR Chiarelli, G Mori, M Šarkan, I Centárová, S Cho, ...
ACS medicinal chemistry letters 7 (3), 266-270, 2016
392016
Synthesis of 3-heteryl substituted pyrrolidine-2, 5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis
T Matviiuk, G Mori, C Lherbet, F Rodriguez, MR Pasca, M Gorichko, ...
European Journal of Medicinal Chemistry 71, 46-52, 2014
392014
Mechanochemical synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity
PFM Oliveira, B Guidetti, A Chamayou, C André-Barrès, J Madacki, ...
Molecules 22 (9), 1457, 2017
322017
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
LR Chiarelli, M Mori, D Barlocco, G Beretta, A Gelain, E Pini, M Porcino, ...
European journal of medicinal chemistry 155, 754-763, 2018
282018
Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth
A Chollet, G Mori, C Menendez, F Rodriguez, I Fabing, MR Pasca, ...
European Journal of Medicinal Chemistry 101, 218-235, 2015
282015
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis
T Matviiuk, J Madacki, G Mori, BS Orena, C Menendez, A Kysil, ...
European Journal of Medicinal Chemistry 123, 462-475, 2016
262016
Shifts of faecal microbiota during sporadic colorectal carcinogenesis
G Mori, S Rampelli, BS Orena, C Rengucci, G De Maio, G Barbieri, ...
Scientific reports 8 (1), 1-11, 2018
242018
New prodrugs against tuberculosis
G Mori, LR Chiarelli, G Riccardi, MR Pasca
Drug discovery today 22 (3), 519-525, 2017
242017
Rv2466c Mediates the Activation of TP053 To Kill Replicating and Non-replicating Mycobacterium tuberculosis
D Albesa-Jové, LR Chiarelli, V Makarov, MR Pasca, S Urresti, G Mori, ...
ACS chemical biology 9 (7), 1567-1575, 2014
232014
New and old hot drug targets in tuberculosis
L Roberto Chiarelli, G Mori, M Esposito, B Silvia Orena, M Rosalia Pasca
Current medicinal chemistry 23 (33), 3813-3846, 2016
202016
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors
M Esposito, S Szadocka, G Degiacomi, BS Orena, G Mori, V Piano, ...
ACS Infectious Diseases 3 (6), 428-437, 2017
182017
Synthesis, oxidation potential and anti–mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism
J Laborde, C Deraeve, L Lecoq, A Sournia‐Saquet, JL Stigliani, BS Orena, ...
ChemistrySelect 1 (2), 172-179, 2016
142016
Triazolophthalazines: easily accessible compounds with potent antitubercular activity
D Veau, S Krykun, G Mori, BS Orena, MR Pasca, C Frongia, V Lobjois, ...
ChemMedChem 11 (10), 1078-1089, 2016
92016
Pyridine-3, 4-dicarboximide as starting material for the total synthesis of the natural product eupolauramine and its isomer iso-eupolauramine endowed with anti-tubercular …
G Perdigao, C Deraeve, G Mori, MR Pasca, G Pratviel, ...
Tetrahedron 71 (10), 1555-1559, 2015
82015
In vitro controlled release of two new tuberculocidal adamantane aminoethers from solid pharmaceutical formulations (II)
M Vlachou, A Siamidi, D Spaneas, D Lentzos, P Ladia, K Anastasiou, ...
Drug research 67 (11), 653-660, 2017
72017
DprE1, a new taxonomic marker in mycobacteria
ML Incandela, E Perrin, M Fondi, AL de Jesus Lopes Ribeiro, G Mori, ...
FEMS microbiology letters 348 (1), 66-73, 2013
72013
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
LR Chiarelli, G Mori, BS Orena, M Esposito, T Lane, ALJL Ribeiro, ...
Scientific reports 8 (1), 1-10, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–20